NCT05943899View on ClinicalTrials.gov

Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

June 30, 2023

Conditions
Type2diabetes
Trial Locations (1)

110048

Fortis CDOC Hospital, New Delhi

All Listed Sponsors
collaborator

National Diabetes Obesity and Cholesterol Foundation

OTHER

lead

Diabetes Foundation, India

OTHER

NCT05943899 - Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis | Biotech Hunter | Biotech Hunter